2016
DOI: 10.1016/j.cmrp.2016.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Altretamine in advanced pretreated epithelial ovarian carcinoma patients: Experience from a center in north India

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…It works as palliation for those with recurrent disease or as a maintenance drug to enhance and increase progression-free survival for these patients. Most benefit of altretamine is the decrease of physical and psychological discomfort came with the parenteral therapies and its oral use decreases the need for hospitalization [53,54].…”
Section: Palliative Care For Ovarian Cancer Patientsmentioning
confidence: 99%
“…It works as palliation for those with recurrent disease or as a maintenance drug to enhance and increase progression-free survival for these patients. Most benefit of altretamine is the decrease of physical and psychological discomfort came with the parenteral therapies and its oral use decreases the need for hospitalization [53,54].…”
Section: Palliative Care For Ovarian Cancer Patientsmentioning
confidence: 99%